Our previous in vitro studies revealed that VPA exerted antitumor effects on Kasumi-1 cells, human acute myeloid leukemia cells with an 8;21 chromosome translocation, via downregulation of VEGF and VEGFR (13,14). The gene discussed is KDR; the disease is acute myeloid leukemia.